AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

AK112, Gemcitabine, CisplatinOngoingActive not recruitingPhase 3Open NCT06591520 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

AK112 Trial NCT06591520: Phase 3, Active, not recruiting | ComplyRx